All-In with Chamath, Jason, Sacks & Friedberg
Inside the GLP-1 Gold Rush: Eli Lilly CEO on New Breakthroughs, Addiction & Mental Health, Pricing
Eli Lilly CEO Dave Ricks joins the All-In podcast to discuss the GLP-1 gold rush, including its impact on weight loss, pricing, and potential uses for addiction and mental health. He also addresses topics such as biotech venture capital, patent hacking, and the role of AI in…